Stemina Biomarker Discovery offers a wide variety of metabolomic services focused on identifying metabolites and biomarkers of many biological processes.
By focusing on changes in the small molecules, either secreted or consumed by cells, the metabolomics platform is capable of identifying metabolite patterns associated with toxicology, cellular response to drugs or chemicals, or biomarkers associated with disease.
The Stemina metabolomics platform is integrated to analyze a wide array of biological materials using highly-sensitive liquid chromatography and mass spectrometry. The highly-complex data is normalized and processed using sophisticated metabolomic univariate and multivariate methods. Working closely with clients to assure project customization, frequent communication, and our commitment to high quality, we deliver:
- Biomarker Discovery
- Predictive Toxicology
- Biomarker Validation
- Biological Pathway Analysis